Literature DB >> 6810913

Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79.

E Ikkala, T Helske, G Myllylä, H R Nevanlinna, P Pitkänen, V Rasi.   

Abstract

Important advances have been made in the treatment of haemophilia during the past 30 years. We have analysed the data of all the known 163 patients with severe haemophilia A living in Finland in 1930-79 in order to study changes in the prognosis of severe haemophilia A. During the period of 50 years the mean age at death of the patients has increased from 7.8 years in 1930-39 to 25.5 years in 1970-79 and the annual death rate has markedly decreased in all age groups. The decline has been greatest in patients under 10 years of age. In this age group the annual death rate decreased from over 50 per thousand in 1930-39 and 1940-49 to 4.8 per thousand in 1970-79. The prognosis of patients with inhibitors has remained poor, however. Five of the six deaths during the last decade occurred in patients with inhibitors. The overall annual death rate of patients without inhibitors was only 1.2 per thousand in 1970-79, suggesting that at the present time the life expectancy of patients who do not develop inhibitors does not markedly differ from that of the general male population.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6810913     DOI: 10.1111/j.1365-2141.1982.tb03856.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  Antihemophilic factor [recombinant], formulated with sucrose.

Authors: 
Journal:  P T       Date:  2010-09

Review 2.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

Review 3.  Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.

Authors:  B T Shannon; J Roach; M Cheek-Luten; C Orosz; F B Ruymann
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

4.  Is major surgery in hemophiliac patients safe?

Authors:  W J Rudowski; R Scharf; J M Ziemski
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

5.  Differentiating pyogenic arthritis from spontaneous hemarthrosis in patients with hemophilia.

Authors:  R T Ellison; L B Reller
Journal:  West J Med       Date:  1986-01

6.  Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

Authors:  Jonathan H Foley; Karl-Uwe Petersen; Catherine J Rea; Lori Harpell; Sandra Powell; David Lillicrap; Michael E Nesheim; Benny Sørensen
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

7.  Sex ratio of the mutation frequencies in haemophilia A: estimation and meta-analysis.

Authors:  F R Rosendaal; A H Bröcker-Vriends; J C van Houwelingen; C Smit; I Varekamp; H van Dijck; T P Suurmeijer; J P Vandenbroucke; E Briët
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

8.  Recombinant factor VIII in the management of hemophilia A: current use and future promise.

Authors:  Jerry S Powell
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

Review 9.  Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.

Authors:  Hans-Christoph Rossbach
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

10.  Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care.

Authors:  Aroub A Khleif; Nidra Rodriguez; Deborah Brown; Miguel A Escobar
Journal:  J Aging Res       Date:  2011-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.